AU745790B2
(en)
*
|
1997-05-13 |
2002-03-28 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory diseases using pADPRT inhibitors
|
US6221888B1
(en)
|
1997-05-29 |
2001-04-24 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
US6291511B1
(en)
|
1997-05-29 |
2001-09-18 |
Merck & Co., Inc. |
Biarylalkanoic acids as cell adhesion inhibitors
|
US5922719A
(en)
*
|
1997-08-11 |
1999-07-13 |
Warner-Lambert Company |
Coumarin dopamine D4 receptor antagonists
|
US6069163A
(en)
*
|
1997-10-21 |
2000-05-30 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
US6020347A
(en)
*
|
1997-11-18 |
2000-02-01 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
US6090841A
(en)
*
|
1997-11-21 |
2000-07-18 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
US6303652B1
(en)
|
1998-08-21 |
2001-10-16 |
Hughes Institute |
BTK inhibitors and methods for their identification and use
|
MXPA00010150A
(en)
*
|
1998-04-17 |
2002-05-14 |
Parker Hughes Inst |
Btk inhibitors and methods for their identification and use.
|
FR2781153B1
(en)
*
|
1998-07-15 |
2001-08-03 |
Lafon Labor |
FLAVONOID-BASED THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF TUMORS WITH CYTOTOXIC AGENTS
|
DE19845372A1
(en)
*
|
1998-10-02 |
2000-04-20 |
Gruenenthal Gmbh |
Use of catechol derivatives as proteinase inhibitors
|
KR20010101203A
(en)
*
|
1998-12-15 |
2001-11-14 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
Use of a MEK Inhibitor for Preventing Transplant Rejection
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
US6331562B1
(en)
|
1998-12-30 |
2001-12-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
WO2000050030A1
(en)
*
|
1999-02-25 |
2000-08-31 |
Ted Ebendal |
New use
|
WO2002008217A2
(en)
*
|
2000-07-21 |
2002-01-31 |
Chugai Seiyaku Kabushiki Kaisha |
COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
|
EP1368024A4
(en)
*
|
2001-03-16 |
2009-03-18 |
Novogen Res Pty Ltd |
Treatment of restenosis
|
KR20020096368A
(en)
*
|
2001-06-19 |
2002-12-31 |
주식회사 티지 바이오텍 |
Mass cell production method of chondrocytes by the inhibition of de-differentiation and a method for screening it
|
KR20020096367A
(en)
*
|
2001-06-19 |
2002-12-31 |
주식회사 티지 바이오텍 |
Pharmaceutical composition for the prevention and treatment of arthritis having effect of essential treatment and a method for screening it
|
AR038136A1
(en)
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
CYCLALCANINDOLS WITH REPLACEMENT WITH FLUOR COMPOSITIONS CONTAINING THESE COMPOUNDS AND TREATMENT METHODS
|
JP4587652B2
(en)
*
|
2002-09-09 |
2010-11-24 |
株式会社フラバミン |
Novel flavonoid compounds and their use
|
CA2497560A1
(en)
|
2002-09-20 |
2004-04-01 |
Promega Corporation |
Luminescence-based methods and probes for measuring cytochrome p450 activity
|
US8138165B2
(en)
*
|
2002-10-22 |
2012-03-20 |
Jenken Biosciences, Inc. |
Chromones and chromone derivatives and uses thereof
|
US7247725B2
(en)
|
2002-10-30 |
2007-07-24 |
Merck & Co., Inc. |
Gamma-aminoamide modulators of chemokine receptor activity
|
US20060252707A1
(en)
*
|
2003-05-28 |
2006-11-09 |
Universite De Liege |
Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin
|
HU229709B1
(en)
|
2004-04-13 |
2014-05-28 |
Incyte Corp Wilmington |
Piperazinyilpiperidine derivatives as chemokine receptor antagonists
|
EP2778234B1
(en)
|
2005-05-31 |
2017-09-27 |
Promega Corporation |
Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
|
US20100068238A1
(en)
*
|
2005-07-15 |
2010-03-18 |
Nandkishore Managoli |
Implantable Medical Devices Comprising a Flavonoid or Derivative Thereof for Prevention of Restenosis
|
AU2006275514B2
(en)
*
|
2005-07-29 |
2012-04-05 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
MEP1008A
(en)
|
2005-12-21 |
2010-02-10 |
Incyte Corp |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
CN1837202B
(en)
*
|
2006-04-25 |
2010-08-18 |
中国人民解放军第二军医大学 |
Flavonols with blood-fat-lowering effect
|
PT2118074E
(en)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compounds for the prevention and treatment of cardiovascular diseases
|
WO2009118338A2
(en)
*
|
2008-03-27 |
2009-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of a polyphenolic type compound for preventing or treating a polyglutamine expansion neurodegenerative disease
|
CA2711103C
(en)
|
2008-06-26 |
2016-08-09 |
Resverlogix Corp. |
Methods of preparing quinazolinone derivatives
|
JP5597200B2
(en)
|
2008-08-18 |
2014-10-01 |
プロメガ コーポレイション |
Compounds producing luminescence and methods for detecting cytochrome P4503A enzyme
|
CA2737483A1
(en)
|
2008-09-22 |
2010-03-25 |
Merck Frosst Canada Ltd. |
Indole derivatives as crth2 receptor antagonists
|
CN102227417B
(en)
*
|
2008-09-29 |
2015-09-16 |
西特里斯药业公司 |
As the chromene keto analog of Sirtuin conditioning agent
|
EP2910945B1
(en)
*
|
2008-09-30 |
2018-07-18 |
Case Western Reserve University |
Molecular probes for imaging of myelin
|
AU2009321221B2
(en)
|
2008-11-26 |
2013-04-04 |
Pfizer Inc. |
3-aminocyclopentanecarboxamides as chemokine receptor modulators
|
CA2747417C
(en)
|
2009-01-08 |
2017-01-03 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
EP2393814A1
(en)
|
2009-02-09 |
2011-12-14 |
SuperGen, Inc. |
Pyrrolopyrimidinyl axl kinase inhibitors
|
NZ594767A
(en)
|
2009-02-24 |
2013-05-31 |
Merck Canada Inc |
Indole derivatives as crth2 receptor antagonists
|
CA3146333A1
(en)
|
2009-03-18 |
2010-09-23 |
Resverlogix Corp. |
Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
|
LT2421533T
(en)
|
2009-04-22 |
2018-12-27 |
Resverlogix Corp. |
Novel anti-inflammatory agents
|
US8927559B2
(en)
|
2010-10-11 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Quinazolinone-type compounds as CRTH2 antagonists
|
WO2012087861A1
(en)
|
2010-12-23 |
2012-06-28 |
Merck Sharp & Dohme Corp. |
Quinoxalines and aza-quinoxalines as crth2 receptor modulators
|
RU2612217C2
(en)
|
2011-05-04 |
2017-03-03 |
Мерк Шарп И Доум Корп. |
Aminopyridine-containing spleen tyrosine kinase (syk) inhibitors
|
CN102274237B
(en)
*
|
2011-06-16 |
2012-12-05 |
成都中医药大学 |
Novel application of flavonoid compound
|
US20140128367A1
(en)
|
2011-06-17 |
2014-05-08 |
Merck Sharp & Dohme Corp. |
Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
JP5992049B2
(en)
|
2011-11-01 |
2016-09-14 |
レスバーロジックス コーポレイション |
Oral immediate release formulations for substituted quinazolinones
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
JP6703484B2
(en)
|
2014-01-29 |
2020-06-03 |
プロメガ コーポレイションPromega Corporation |
Quinone-masked probe as a labeling reagent for cellular uptake measurements
|
WO2016123141A1
(en)
*
|
2015-01-26 |
2016-08-04 |
Berreau Lisa M |
Carbon monoxide releasing molecules and associated methods
|
GB2585171B
(en)
|
2015-02-19 |
2021-03-24 |
Council Scient Ind Res |
An antioxidant compound having anti atherosclerotic effect and preparation thereof
|
WO2016147053A1
(en)
|
2015-03-13 |
2016-09-22 |
Resverlogix Corp. |
Compositions and therapeutic methods for the treatment of complement-associated diseases
|
KR101837690B1
(en)
*
|
2016-04-04 |
2018-03-13 |
한국한의학연구원 |
Compostion for prevention or treatment restenosis comprising Alpinia officinarum Hance extracts, fractions or galangin seperated from therefrom
|
DE102016223763A1
(en)
*
|
2016-11-30 |
2018-05-30 |
Beiersdorf Ag |
Use of 2'-methoxyflavone in cosmetic or dermatological preparations for the prophylaxis and treatment of sensitive skin
|
CN109265424B
(en)
*
|
2018-09-25 |
2020-08-21 |
天津中医药大学 |
Flavonoid derivative and preparation method and identification method thereof
|
JP2022517610A
(en)
|
2019-01-10 |
2022-03-09 |
シーエスピーシー ゾンチー ファーマシューティカル テクノロジー(シージアチュアン)カンパニー,リミテッド |
Heterocyclic compound salts and their use
|